Microarray study of mechanism of trichostatin a inducing apoptosis of Molt-4 cells

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 29, Issue 4, 2009, Pages 445-450

  Hong, Zhenya ^a   Han, Zhiqiang ^a   Xiao, Min ^a   Yang, Yang ^a   Xia, Xi ^a   Zhou, Jianfeng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Difference in gene expression; Microarray; MOLT 4 cells; Trichostatin A

Indexed keywords

HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; MYC PROTEIN; MYC PROTEIN, HUMAN; STAT5 PROTEIN; TRICHOSTATIN A;

APOPTOSIS; ARTICLE; DRUG EFFECT; GENETICS; HUMAN; LEUKEMIA; METABOLISM; MICROARRAY ANALYSIS; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; LEUKEMIA; MICROARRAY ANALYSIS; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAT5 TRANSCRIPTION FACTOR;

EID: 68949107217     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-009-0411-y     Document Type: Article

References (26)

1. S. Minucci P.G. Pelicci 2006 Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer Nat Rev Cancer 6 1 38 51
2. M. De los Santos A. Zambrano A. Aranda 2007 Combined effects of retinoic acid and histone deacetylase inhibitors on human neuroblastoma SH-SY5Y cells Mol Cancer Ther 6 4 1425 1432
3. J. Vlasáková Z. Nováková L. Rossmeislová 2007 Histone deacetylase inhibitors suppress IFNalpha-induced up-regulation of promyelocytic leukemia protein Blood 109 4 1373 1380
4. C.L. Dalgard K.R. Van Quill J.M. O'Brien 2008 Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma Clin Cancer Res 14 10 3113 3123
5. E.J. Noh D.S. Lim G. Jeong 2009 An HDAC inhibitor, trichostatin A, induces a delay at G2/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner Biochem Biophys Res Commun 378 3 326 331
6. W.K. Chen Y. Chen J.X. Gu 2004 Effect of trichostatin A on histone acetylation level and apoptosis in HL-60 cells J Exp Hematol 12 3 324 328
7. J. Zhou Q. Gao G. Chen 2005 Novel oncolytic adenovirus selectively targets tumor-associated polo-like kinase 1 and tumor cell viability Clin Cancer Res 11 23 8431 8440
8. A. Miyanaga A. Gemma R. Noro 2008 Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model Mol Cancer Ther 7 7 1923 1930
9. S. Roy A.C. Shor T.K. Bagui 2008 Histone deacetylase 5 represses the transcription of cyclin D3 J Cell Biochem 104 6 2143 2154
10. H. Yu R. Jove 2004 The STATs of cancer-new molecular targets come of age Nat Rev Cancer 4 2 97 105
11. J.N. Ihle 1996 STATs: signal transducers and activators of transcription Cell 84 331 334
12. J.E. Darnell Jr. 1997 STATs and gene regulation Science 277 1630 1635
13. J.S. Rawlings K.M. Rosler D.A. Harrison 2004 The JAK/STAT signaling pathway J Cell Sci 117 Pt8 1281 1283
14. P. Defilippi A. Rosso P. Dentelli 2005 {beta} 1 Integrin and IL-3R coordinately regulate STAT5 activation and anchorage-dependent proliferation J Cell Biol 168 7 1099 1108
15. C. Sebastián M. Serra A. Yeramian 2008 Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells J Immunol 180 9 5898 5906
16. A.T. Wierenga E. Vellenga J.J. Schuringa 2008 Maximal STAT5-induced proliferation and self-renewal at intermediate STAT5 activity levels Mol Cell Biol 28 21 6668 6680
17. N. Harir C. Boudot K. Friedbichler 2008 Oncogenic kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade Blood 112 6 2463 2473
18. + angiogenic cells and their arterial commitment via STAT5 activation Blood 112 2 350 361
19. L. Hennighausen G.W. Robinson 2008 Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B Genes Dev 22 6 711 721
20. Hosui A, Kimura A, Yamaji D, et al. Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-ta and STAT3 activation. J Exp Med, 2009,206(4):819-831
21. X. Yang D. Qiao K. Meyer 2009 Signal transducers and activators of transcription mediate fibroblast growth factor-induced vascular endothelial morphogenesis Cancer Res 69 4 1668 1677
22. B.W. Freie R.N. Eisenman 2008 Ratcheting Myc Cancer Cell 14 6 425 426
23. Z. Li D. Boone S.R. Hann 2008 Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation Proc Natl Acad Sci USA 105 48 18794 18799
24. J.C. Acosta N. Ferrándiz G. Bretones 2008 Myc inhibits p27-induced erythroid differentiation of leukemia cells by repressing erythroid master genes without reversing p27-mediated cell cycle arrest Mol Cell Biol 28 24 7286 7295
25. X.L. Xu Y. Fang T.C. Lee 2009 Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling Cell 137 6 1018 1031
26. E. Ceballos M.J. Munoz-Alonso B. Berwanger 2005 Inhibitory effect of c-Myc on p53-induced apoptosis in leukemia cells. Microarray analysis reveals defective induction of p53 target genes and upregulation of chaperone genes Oncogene 24 28 4559 4571